FILING ANALYSIS · FRIDAY, NOVEMBER 13
DataMeds AI, Inc. MEDS — 8-K: Results of Operations and Financial Condition
positive
DataMeds AI reports 50% sequential revenue growth and a net profit per share of $2.72, driven by growth in Corexa Pharmacy, and announces several new business developments, including the launch of the Health Lives Here mobile app and the acquisition of Helomics cancer diagnostics laboratory.
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →